Literature DB >> 15519287

The National Lipid Association surveys of consumers, physicians, and pharmacists regarding an over-the-counter statin in the United States: is this a good idea?

James M McKenney1, W Virgil Brown, Jerome D Cohen, Edward Cahill.   

Abstract

Surveys commissioned by the National Lipid Association (NLA) were conducted to determine the current attitudes and perceptions of physicians, consumers, and pharmacists regarding the impact of an over-the-counter (OTC) statin. Individuals from preexisting independent databases were randomly invited to participate in the online surveys that were open from January 26 to 30, 2004 for physicians and consumers and from March 1 to 12, 2004 for pharmacists. The results of these surveys indicate that consumers and pharmacists are more positive regarding the idea of an OTC statin, whereas physicians are more guarded. Concerns of both physicians and pharmacists included the discontinuation by patients of their prescription cholesterol-lowering therapy without consulting their physician, safety issues such as potential drug interactions and side effects, and patient ability to self-manage OTC statins. Consumers interested in purchasing an OTC statin reported that they would consult their physician before doing so, and pharmacists were interested in supporting consumers who use OTC statins. Although such support would require further training and time, pharmacists believed that they could facilitate consumer self-care programs and follow-up with physicians.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15519287     DOI: 10.1016/j.amjcard.2004.07.050

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  7 in total

1.  Community pharmacists' views, attitudes and early experiences of over-the-counter simvastatin.

Authors:  Denise Hansford; Scott Cunningham; Dai John; Dorothy McCaig; Derek Stewart
Journal:  Pharm World Sci       Date:  2007-03-15

Review 2.  Should cholesterol-lowering medications be available in Canada without a prescription?

Authors:  Shirya Rashid
Journal:  Can J Cardiol       Date:  2007-03-01       Impact factor: 5.223

3.  American, British and European recommendations for statins in the primary prevention of cardiovascular disease applied to British men studied prospectively.

Authors:  P McElduff; M Jaefarnezhad; P N Durrington
Journal:  Heart       Date:  2006-05-22       Impact factor: 5.994

4.  The Food and Drug Administration and over-the-counter statins: an opportunity lost?

Authors:  Thomas G Pickering
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-03       Impact factor: 3.738

5.  Over-the-counter statin therapy--pros and cons.

Authors:  Domenic A Sica
Journal:  J Clin Hypertens (Greenwich)       Date:  2005-05       Impact factor: 3.738

6.  Patient attitudes towards a new role for pharmacists: continued dispensing.

Authors:  Salem Hasn Abukres; Kreshnik Hoti; Jeffery David Hughes
Journal:  Patient Prefer Adherence       Date:  2014-08-27       Impact factor: 2.711

Review 7.  Over-the-counter medicines: Global perspective and Indian scenario.

Authors:  P A Marathe; S K Kamat; R K Tripathi; S B Raut; N P Khatri
Journal:  J Postgrad Med       Date:  2020 Jan-Mar       Impact factor: 1.476

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.